Quarterly report pursuant to Section 13 or 15(d)

Note 10 - Stock-based Compensation and Employee Benefits Plans - Changes in Stock Options Outstanding (Details)

v3.21.2
Note 10 - Stock-based Compensation and Employee Benefits Plans - Changes in Stock Options Outstanding (Details) - $ / shares
6 Months Ended 12 Months Ended
Sep. 25, 2021
Mar. 27, 2021
Outstanding, Shares (in shares) 374,808 240,758
Outstanding, weighted average exercise price (in dollars per share) $ 5.00 $ 5.86
Outstanding, Weighted average remaining contractual terms (Year) 7 years 7 months 24 days 7 years 10 months 24 days
Granted, Shares (in shares) 39,000 148,000
Granted, weighted average exercise price (in dollars per share) $ 2.86 $ 3.53
Granted, Weighted average remaining contractual terms (Year) 9 years 9 months 3 days 9 years 2 months 12 days
Forfeited/Expired (in shares) (15,958) (13,950)
Forfeited/Expired (in dollars per share) $ 4.05 $ 4.15
Outstanding, Shares (in shares) 397,850 374,808
Outstanding, weighted average exercise price (in dollars per share) $ 4.86 $ 5.00
Exercisable, Shares (in shares) 170,900  
Exercisable, weighted average exercise price (in dollars per share) $ 6.18  
Exercisable, Weighted average remaining contractual terms (Year) 5 years 11 months 26 days  
Expected to vest in the future, Shares (in shares) 226,950  
Expected to vest in the future, weighted average exercise price (in dollars per share) $ 3.86  
Expected to vest in the future, Weighted average remaining contractual terms (Year) 8 years 9 months 7 days